Jayesh Beladiya
Overview
Explore the profile of Jayesh Beladiya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rana D, Beladiya J, Sheth D, Kumar H, Jindal A, Shah G, et al.
Int J Pharm
. 2024 Oct;
666:124783.
PMID: 39353497
Dry eye syndrome (DES) presents a significant challenge in ophthalmic care, necessitating innovative approaches for effective management. This research article introduces a multifaceted strategy to address DES through the development...
2.
Beladiya J, Kumar A, Vasava Y, Parmar K, Patel D, Patel S, et al.
Rev Med Virol
. 2024 Jul;
34(5):e2573.
PMID: 39085164
No abstract available.
3.
Joshi R, Sheth D, Beladiya J, Patel C, Solanki N, Dalal M, et al.
Curr Drug Discov Technol
. 2024 Jun;
PMID: 38859789
In underdeveloped nations, tuberculosis (TB) continues to be a major source of morbidity and mortality. The currently available vaccine against tuberculosis in endemic areas is mainly ineffective, which triggers the...
4.
Beladiya J, Kumar A, Vasava Y, Parmar K, Patel D, Patel S, et al.
Rev Med Virol
. 2024 Jan;
34(1):e2507.
PMID: 38282394
Vaccines against coronavirus disease 2019 (COVID-19) have been discovered within a very small duration of time as compared to the traditional way for the development of vaccines, which raised the...
5.
Pande S, Patel C, Dhameliya T, Beladiya J, Parikh P, Kachhadiya R, et al.
In Silico Pharmacol
. 2024 Jan;
12(1):8.
PMID: 38204437
Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-023-00182-0.
6.
Rana D, Beladiya J, Sheth D, Salave S, Sharma A, Jindal A, et al.
J Pharm Sci
. 2023 Dec;
113(5):1339-1350.
PMID: 38123067
Ocular inserts offer distinct advantages, including a preservative-free drug delivery system, the ability to provide tailored drug release, and ease of administration. The present research paper delves into the development...
7.
Sagathia V, Patel C, Beladiya J, Patel S, Sheth D, Shah G
Naunyn Schmiedebergs Arch Pharmacol
. 2023 Jun;
396(12):3363-3374.
PMID: 37338576
Tankyrase 1 (TNKS1) and tankyrase 2 (TNKS2) enzymes belong to the poly (ADP-ribose) polymerase (PARP) family participates in process of poly-ADP-ribosylation of different target proteins which leads to ubiquitin-mediated proteasomal...
8.
Patel C, Pande S, Sagathia V, Ranch K, Beladiya J, Boddu S, et al.
Pharmaceutics
. 2023 Mar;
15(3).
PMID: 36986699
Retinal neurodegeneration is considered an early event in the pathogenesis of several ocular diseases, such as diabetic retinopathy, age-related macular degeneration, and glaucoma. At present, there is no definitive treatment...
9.
Patel B, Sheth D, Vyas A, Shah S, Parmar S, Patel C, et al.
Metab Brain Dis
. 2022 Jul;
37(7):2533-2543.
PMID: 35900690
DPP-4 inhibitors have been shown to reverse amyloid deposition in Alzheimer's disease (AD) patients with cognitive impairment. Ocimum sanctum L. leaves reported the presence of important phytoconstituents which are reported...